JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
AnaptysBio to Participate in Upcoming Investor Conferences
-
Minerva Neurosciences (NERV) PT Raised to $20 at JMP Securities
-
Palo Alto Networks (PANW) PT Raised to $165 at JMP Securities, " Solid Quarter Highlights Progress in Sales Transition"
-
Orthofix to Present at Healthcare Conferences in June 2017
-
Axovant Sciences to Present at Upcoming Investor Conferences
-
BlackLine Announces Closing of Follow-On Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
Bovie Medical Corporation to Present at the JMP Securities Life Sciences Conference
-
Entasis Therapeutics to Present at Upcoming June 2017 Investor Conferences
-
Oryzon Genomics to Participate in a Panel at the JMP Securities Life Sciences Conference and Present at the Jefferies 2017 Global Health Conference
-
Karyopharm Therapeutics to Participate in Upcoming Investor Conferences
-
Insys Therapeutics, Inc. to Present at June Conferences
-
MVC Capital (MVC) Portfolio Holding US Gas & Electric To Be Acquired By Crius Energy For $172.5 Million In Cash And Second-Lien Notes
-
U.S. Gas & Electric to be Acquired by Crius Energy Trust
-
Envestnet to Attend Spring Conferences
-
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
-
Flex Pharma Presenting at Upcoming Investor Conferences in June 2017
-
CounterTack Announces $20M Series D Growth Round of Funding Led by Singtel Innov8 and SAP NS2
-
Concert Pharmaceuticals to Present at Upcoming Investor Conferences
-
JMP Securities Starts Ovid Therapeutics Inc (OVID) at Market Outperform, "Building a Leader in Orphan Neurology"
-
Horizon Pharma plc to Participate in Upcoming Conferences
-
JMP Securities Downgrades Beazer Homes (BZH) to Market Underperform
-
Halozyme Therapeutics To Present At Upcoming Healthcare Conferences
-
American Biltrite, Inc. (BL) Prices 3.48M Share Follow-On Offering at $33/Sh
-
MINDBODY (MB) Prices 4.4M Share Follow-On Offering at $27.95/Sh
-
JMP Securities Starts Clearside Biomedical (CLSD) at Market Outperform
-
Blackline Announces Pricing of Follow-On Offering
-
MINDBODY Announces Pricing of Follow-On Offering
-
Halozyme Therapeutics Announces Completion Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares
-
Integra LifeSciences to Present at Healthcare Conferences in June 2017
-
JMP Securities Upgrades First Solar (FSLR) to Market Outperform, Says Stock Has More Upside As USITC Case Enters Next Phase
-
Cybereason Discovers Large-scale Corporate Espionage Hacking Operation
-
JMP Securities Starts Atlas Financial (AFH) at Market Outperform
-
Intrexon to Present at Upcoming Investor and Industry Conferences
-
Atara Biotherapeutics to Present at Three Upcoming Investor Conferences
-
argenx announces closing of NASDAQ IPO
-
JMP Securities Starts Cloudera (CLDR) at Market Perform
-
JMP Securities Starts Carvana (CVNA) at Market Outperform
-
Compugen to Present at Two Upcoming Investor Conferences in June
-
MINDBODY (MB) to Offer 4.4M Shares
-
MINDBODY Announces Proposed Follow-On Offering
-
Pre-Open Movers 05/22: (NUTR) (RDUS) (EYEG) Higher; (LJPC) (SNCR) (AMGN) Lower (more...)
-
JMP Securities Upgrades Cree (CREE) to Market Outperform; Potential for Significant Change as CEO Retires
-
salesforce.com (CRM) PT Raised to $95 at JMP Securities; Reiterates Outperform
-
argenx announces full exercise of underwriters' option to purchase additional ADSs
-
JMP Securities Starts Spring Bank Pharmaceuticals (SBPH) at Market Outperform; Positive Ahead of Data
-
Halozyme Therapeutics (HALO) Prices 10M Share Offering at $12.50/Sh
-
Halozyme Therapeutics Prices Public Offering Of Common Stock
-
Vertex Pharma (VRTX): Raising PT - JMP
-
MindTouch Increasing Its Commitment to Proprietary "Smart Content" Framework with Advanced Optimization Tools
-
AtriCure to Present at the JMP Securities Life Science Conference

